Precigen
PGEN
#5417
Rank
S$1.92 B
Marketcap
S$5.37
Share price
-2.58%
Change (1 day)
-14.86%
Change (1 year)

Earnings for Precigen (PGEN)

Earnings in 2026 (TTM): S$31.57 Million

According to Precigen's latest financial reports the company's current earnings are S$0.15 Billion. In 2025 the company made an earning of -S$0.33 Billion a decrease over its 2024 earnings that were of -S$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Precigen from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$31.57 M-109.76%
2025 -S$0.33 Billion95.77%
2024 -S$0.17 Billion32.86%
2023 -S$0.13 Billion20.5%
2022 -S$0.11 Billion-23.33%
2021 -S$0.14 Billion60.11%
2020 -S$84.13 Million-65.1%
2019 -S$0.25 Billion-65.19%
2018 -S$0.7 Billion313.44%
2017 -S$0.17 Billion-33.2%
2016 -S$0.26 Billion123.22%
2015 -S$0.12 Billion1.47%
2014 -S$0.12 Billion109.54%
2013 -S$52.84 Million-50.04%
2012 -S$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Organovo
ONVO
-S$3.22 Million-110.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-S$94.36 Million-396.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-S$0.29 Billion-1,008.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-S$0.12 Billion-465.61% Jersey